AOD-9604: GH Fragment for Fat Loss

Growth hormone burns fat. Everyone knows this. But full GH therapy comes with side effects: water retention, joint pain, insulin resistance, potential tumor growth stimulation. AOD-9604 takes the fat-burning piece of GH and leaves everything else behind.

What AOD-9604 is

AOD-9604 is a modified fragment of human growth hormone, specifically amino acids 177-191 from the C-terminal end. This fragment was identified in the 1990s by researchers at Monash University in Australia as the portion responsible for GH's lipolytic (fat-burning) activity.

The "AOD" stands for Advanced Obesity Drug. The modification includes a tyrosine residue at the start that stabilizes the fragment and improves its fat-metabolism effects.

The critical point: AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) without affecting blood sugar, IGF-1 levels, or growth. It's the fat-burning part of GH, extracted and isolated.

Mechanism

AOD-9604 activates the beta-3 adrenergic receptor pathway in adipose tissue. This is the same pathway that catecholamines (adrenaline, noradrenaline) use to trigger fat breakdown during exercise or fasting. But AOD-9604 doesn't raise heart rate or blood pressure the way stimulants do.

It also appears to upregulate fatty acid oxidation in mitochondria (Heffernan et al., 2001). So not only does it release fatty acids from fat cells, it helps the body actually burn them for energy rather than re-storing them.

And unlike full GH, it doesn't raise IGF-1. In a study by Ng et al. (2000), AOD-9604 reduced body fat in obese mice without any change in IGF-1 levels or fasting glucose. No diabetogenic effect. No growth promotion. Just lipolysis.

Clinical data

A Phase IIb clinical trial (2004) tested oral AOD-9604 in 300 obese adults over 24 weeks. The results were modest for the oral form (limited bioavailability), but subcutaneous administration in earlier studies showed stronger effects. A 2001 study demonstrated significant fat mass reduction in obese Zucker rats at doses equivalent to 250-500mcg/day in humans.

AOD-9604 received GRAS (Generally Recognized as Safe) status from the FDA in 2010 for use as a food ingredient. While this isn't the same as drug approval, it speaks to the safety profile.

The Australian research program was eventually deprioritized in favor of GLP-1 agonists, which showed stronger weight loss numbers. But AOD-9604 has a different use case: targeted fat loss without appetite suppression, insulin disruption, or the GI side effects that come with GLP-1 peptides.

Dosing

Research protocols typically use 250-500mcg/day subcutaneously, usually on an empty stomach (morning fasting works well). Some protocols suggest 5 days on, 2 days off. Course length: 4-12 weeks.

[[AOD-9604|16]] is available in vial format. Reconstitute with bacteriostatic water. At 300mcg/day, a vial provides enough for a multi-week research course.

Side effects

Remarkably mild compared to other fat loss compounds. The whole point of using a fragment instead of full GH is avoiding side effects.

Reported in studies: occasional headache, injection site irritation. No significant effects on blood glucose, insulin, IGF-1, cortisol, or thyroid markers. No water retention. No joint pain.

If you've avoided GH peptides because of the side effect profile, AOD-9604 is worth looking at specifically because it doesn't carry that baggage.

AOD-9604 vs appetite suppressors

Tirzepatide, retatrutide, cagrilintide all work by making you eat less. AOD-9604 doesn't touch appetite. It directly mobilizes and oxidizes fat. These are complementary approaches, not competing ones. Some researchers combine AOD-9604 with a GLP-1 agonist for dual-mechanism fat loss.

Who this is for

If you want targeted fat loss without appetite suppression effects. If full GH or GH secretagogues have side effects you want to avoid. If you're looking for something that works alongside a caloric deficit to accelerate fat mobilization specifically.

Check out [[AOD-9604|16]]. Need help with protocol design? Reach out to us.

This article is for educational purposes. Peptides are intended for research use. Consult a healthcare professional before starting any protocol.